Mindtension News
3 articles
growth-negative
Traumatized southern startup determined to keep working - ISRAEL21c
MindTension, an Israeli startup founded in 2020, is developing a device that diagnoses ADHD by measuring the brainstem’s reflexive response to specific sounds. The companys offices are located near the Gaza border, in Kibbutz Nir Am, which was recently under attack. While the offices were unharmed, several employees were affected, with some losing family members and others being evacuated from their homes. Despite the trauma, the company is looking forward and is currently seeking FDA approval in the United States for its device.
CustomersManagement Changes
growth-positive
"There is a $5 billion opportunity in the ADHD market" | CTech
MindTension, a digital health and medical device company, has raised $2 million to date for its tool that helps diagnose and treat ADHD and related mental health comorbidities. The companys technology measures the reflexive response of the brainstem to auditory sounds, determining the precise level of attention deficit for precise treatment. The technology can also be used to assess the attention of professionals in high-risk, high-attention professions. The company plans to tap into a $50 billion opportunity in the fit to operate market. MindTension was founded in 2020 by Zev Brand and Prof. Avi Avital.
InvestmentExpand
growth-positive
Simple Six-Minute Blink Test That Diagnoses ADHD
Israeli company MindTension has developed a fully objective test for diagnosing ADHD. The test measures the reaction of a persons eyelid muscles to different noises, a reflexive response that cannot be manipulated. The company claims this test is uncheatable and is constantly improving due to its use of machine learning and AI. MindTension is currently working towards FDA approval and is conducting clinical trials in Southern Israel and the US. The company plans to start selling the device by the second half of 2024.
CustomersExpand
